Mounjaro 5mg KwikPen (4 Shots)
Mounjaro (tirzepatide) is a clinically proven, prescription-only weight management medication and a cornerstone of Patient First’s longevity medicine practice. It activates both GLP-1 and GIP receptors to reduce appetite, lower caloric intake, and improve metabolic function at a hormonal level — supported by clinical evidence as one of the most effective medical interventions for sustainable weight management.
The 5mg dose is for patients progressing in their program, prescribed by our doctors based on their individual response and clinical clearance.
This program is for patients who have completed pre-screening and hold a valid prescription for 5mg tirzepatide. It is the next step in a medically supervised longevity medicine program at Patient First — continuing the physician-directed approach to weight management that prioritizes safety, measurable outcomes, and long-term metabolic health.
Pre-screening is required before purchase. Please contact us to arrange your consultation and diagnostic tests before proceeding.

















